Culture Biosciences has reeled in $5.5 million in funding to be used to expand its operations.
Velocity Clinical Research is shelling out $20 million from a recent fundraising to acquire its first three research sites.
Decibel Therapeutics taps 46 Clinical to provide randomization and trial supply management.
Charles River has added another string to its early-stage R&D bow by acquiring preclinical services firm Citoxlab for $510 million in cash.
The revolving door of FDA staffers into the life science industry continues as four former executives at the U.S. regulator join the CRO’s ranks.
The Canada-based units of Boehringer Ingelheim and IBM will work together to employ blockchain record-keeping technology in clinical trials.
Aetion closes on a $27 million extension of series B financing.
Moderna has opted to enter a licensing deal with U.K.-based Avacta Group to use the U.K.-based company’s Affimer biotherapeutics and reagents.
Welsh CRO Simbec-Orion was acquired by U.K.-based private equity firm CBPE Capital for an undisclosed price.
MMS Holdings, MIT Julia Lab and the University of Maryland form the Health Analytics Collective.
